Borregaard ASA BRG
Oslo Børs · Råvarer · Specialty Chemicals
Ha denne aksjen på overvåkingslisten din og sett opp e-postvarsler om kurser, rapporter og viktige meldinger der det er tilgjengelig.
Guiding fra Borregaard
BetaHva selskapet sier det forventer, og hvor ofte det har levert på det.
Guiding i siste rapport
- BioSolutions sales volume (FY 2026)
“For BioSolutions, sales volume for 2026 is forecast to be 335,000 tonnes.” (s. 12) - BioSolutions sales volume (Q3 2026)
“Sales volume in the 3rd quarter is expected to be approximately 85,000 tonnes.” (s. 12) - BioMaterials sales volume to exceed 160,000 tonnes (FY 2026)
“For BioMaterials, sales volume is forecast to exceed 160,000 tonnes in 2026.” (s. 12) - BioMaterials sales volume (Q3 2026)
“In the 3rd quarter, sales volume is expected to be approximately 40,000 tonnes.” (s. 12) - BioMaterials volume of highly specialised grades higher than 2025 (FY 2026)
“Sales volume of highly specialised grades is expected to be higher than in 2025.” (s. 12) - Bioethanol sales prices largely in line with 2025 (FY 2026)
“Sales prices for bioethanol are expected to be largely in line with 2025.” (s. 12) - Fine chemical intermediates sales volume increase vs 2025 (FY 2026)
“Sales volume for fine chemical intermediates is expected to increase compared with 2025.” (s. 12) - Lower bioethanol deliveries and weaker product mix for fine chemical intermediates in H2 vs H1 (H2 2026)
“Deliveries of bioethanol are expected to be lower, and the product mix for fine chemical intermediates will be weaker in the 2nd half of 2026 compared with the 1st half of the year.” (s. 12) - Wood costs lower in H2 2026 vs H1 2026 (H2 2026)
“Borregaard's wood costs in the 2nd half of 2026 are expected to be 3-4% lower compared with the 1st half of 2026.” (s. 12) - Cost improvement programme, annual cost savings, full effect from 2028 (2028)
“Borregaard is implementing a cost improvement programme targeting annual cost savings of NOK 150 million.” (s. 12) - Net FX impact on EBITDA vs Q3 2025 (Q3 2026)
“Borregaard expects a net impact of foreign exchange on EBITDA1 of approximately NOK 10 million in the 3rd quarter of 2026” (s. 9) - Net FX impact on EBITDA vs 2025 (FY 2026)
“approximately NOK 10 million in the 3rd quarter of 2026 and NOK 45 million for the full year of 2026, compared with the corresponding periods in 2025.” (s. 9)
Guiding mot utfall
| Gitt | Hva | Periode | Guidet | Faktisk | Utfall |
|---|---|---|---|---|---|
| 2022-10-21 | Omsetning In BioMaterials, the average price in sales currency is expected to increase 4-6% in... |
Q4 2022 | 4,0 % – 6,0 % | 22,4 % | Over |
| 2021-07-15 | Omsetning Sales growth will continue for cellulose fibrils, and new business development and... |
2021 | Opp (fra 3 990) | 5 805 | Truffet |
| 2021-02-03 | Omsetning In BioMaterials, the average price in sales currency is expected to be 2-3% below the... |
2021 | Ned (fra 3 990) | 5 805 | Over |
| 2016-07-18 | Omsetning In 2016, average cellulose price in sales currency is expected to be approximately 2%... |
2016 | Ned (fra 4 164) | 1 113 | Truffet |
| 2016-02-03 | Omsetning average cellulose price in sales currency are expected to be approximately 3% below... |
2016 | Ned (fra 4 164) | 1 113 | Truffet |
Beløp i NOK millioner. Hvert utfall teller fra dagen rapporten med det faktiske tallet ble publisert, slik en backtest ser det. Hold over et nøkkeltall for rapportens egne ord; klikk på datoen eller det faktiske tallet for å åpne rapporten på riktig side.
Guiding teller bare når den nevner et år eller kvartal og et tall rapportene viser: omsetning, driftsresultat, marginer, EPS og nøkkeltall for bank og forsikring. Lest av en AI-modell og kan være feil. Ikke investeringsråd.
Ikke investeringsråd. Tallene kan inneholde feil fra datakilden.